News
 

Certain drugs currently used to treat benign prostatic hyperplasia (BPH) may provide neuroprotection and delay or prevent the onset of Parkinson's disease.

Limited data support the benefits of non-vitamin K oral anticoagulants (NOACs) among atrial fibrillation patients with prior gastrointestinal bleeding (GIB).

Afternoon napping by older adults is tied to better memory and improved language skills, new research suggests.

The incidence of idiopathic intracranial hypertension (IIH) - characterized by increased cerebral spinal fluid (CSF) pressure - is rising considerably, corresponding to population increases in body mass index (BMI), a new study has shown.

Source: JAMA. 2021;325(4):373-381. doi:10.1001/jama.2020.25071

Heavy alcohol use in adolescence is linked to disruptions in white matter integrity, new research suggests. (JAMA Psychiatry. Published online December 30, 2020. doi:10.1001/jamapsychiatry.2020.4064)

A new research study (EXPAND) has been conducted to investigate the effects of siponimod on cognitive processing speed in patients with secondary progressive (SP) multiple sclerosis (MS).

Atabecestat, a nonselective oral β-secretase inhibitor, was evaluated in the EARLY trial for slowing cognitive decline in participants with preclinical Alzheimer disease. Preliminary analyses suggested dose-related cognitive worsening and neuropsychiatric adverse events (AEs).

A new study suggests that the virus might actually damage the brain's small blood vessels rather than nerve cells themselves.

Whether anti-seizure medication (ASM) increases the risk for cancer has been debated for decades. While for some ASM, a carcinoma-promoting effect has been suspected, carcinoma-protective effects have been shown for other ASM. However, the issue remains unresolved as data from preclinical and clinical studies have been inconsistent and...